These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18215114)
1. A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo. Konopka JL; Penalva LO; Thompson JM; White LJ; Beard CW; Keene JD; Johnston RE PLoS Pathog; 2007 Dec; 3(12):e199. PubMed ID: 18215114 [TBL] [Abstract][Full Text] [Related]
2. Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. Schäfer A; Whitmore AC; Konopka JL; Johnston RE J Virol; 2009 May; 83(9):4275-86. PubMed ID: 19225006 [TBL] [Abstract][Full Text] [Related]
3. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. Schoneboom BA; Lee JS; Grieder FB J Interferon Cytokine Res; 2000 Feb; 20(2):205-15. PubMed ID: 10714557 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054 [TBL] [Abstract][Full Text] [Related]
5. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. MacDonald GH; Johnston RE J Virol; 2000 Jan; 74(2):914-22. PubMed ID: 10623754 [TBL] [Abstract][Full Text] [Related]
6. Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge. Konopka JL; Thompson JM; Whitmore AC; Webb DL; Johnston RE J Virol; 2009 Dec; 83(23):12432-42. PubMed ID: 19793821 [TBL] [Abstract][Full Text] [Related]
7. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984 [TBL] [Abstract][Full Text] [Related]
9. Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus. Bhalla N; Sun C; Metthew Lam LK; Gardner CL; Ryman KD; Klimstra WB Virology; 2016 Sep; 496():147-165. PubMed ID: 27318152 [TBL] [Abstract][Full Text] [Related]
10. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
12. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus. Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152 [TBL] [Abstract][Full Text] [Related]
13. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region. White LJ; Wang JG; Davis NL; Johnston RE J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360 [TBL] [Abstract][Full Text] [Related]
14. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1. Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742 [TBL] [Abstract][Full Text] [Related]
15. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection. Yao Z; Zanini F; Kumar S; Karim M; Saul S; Bhalla N; Panpradist N; Muniz A; Narayanan A; Quake SR; Einav S PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009306. PubMed ID: 33788849 [TBL] [Abstract][Full Text] [Related]
16. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Grieder FB; Vogel SN Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925 [TBL] [Abstract][Full Text] [Related]
17. Development of reverse transcription-PCR assays specific for detection of equine encephalitis viruses. Linssen B; Kinney RM; Aguilar P; Russell KL; Watts DM; Kaaden OR; Pfeffer M J Clin Microbiol; 2000 Apr; 38(4):1527-35. PubMed ID: 10747138 [TBL] [Abstract][Full Text] [Related]
18. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110 [TBL] [Abstract][Full Text] [Related]
19. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus]. Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922 [TBL] [Abstract][Full Text] [Related]
20. Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain. Bhomia M; Balakathiresan N; Sharma A; Gupta P; Biswas R; Maheshwari R Biochem Biophys Res Commun; 2010 Apr; 395(1):11-6. PubMed ID: 20303929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]